ArticleCannabis and cannabinoid research2022

Re: "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" by Crippa et al.

Luis Vitetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.